These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
306 related articles for article (PubMed ID: 33034128)
1. IL-10 producing type 2 innate lymphoid cells prolong islet allograft survival. Huang Q; Ma X; Wang Y; Niu Z; Wang R; Yang F; Wu M; Liang G; Rong P; Wang H; Harris DC; Wang W; Cao Q EMBO Mol Med; 2020 Nov; 12(11):e12305. PubMed ID: 33034128 [TBL] [Abstract][Full Text] [Related]
2. Potential correlation of allograft infiltrating group 2 innate lymphoid cells with acute rejection after liver transplantation. Sun J; Zhou GP; Li SP; Chen XJ; Zhang JM; Jiang YZ; Cui B; Zhang HM; Sun LY; Zhu ZJ Front Immunol; 2022; 13():953240. PubMed ID: 35967423 [TBL] [Abstract][Full Text] [Related]
3. Group 2 innate lymphoid cells promote TNBC lung metastasis via the IL-13-MDSC axis in a murine tumor model. Zhao N; Zhu W; Wang J; Liu W; Kang L; Yu R; Liu B Int Immunopharmacol; 2021 Oct; 99():107924. PubMed ID: 34217145 [TBL] [Abstract][Full Text] [Related]
4. Group 2 innate lymphoid cells contribute to IL-33-mediated alleviation of cardiac fibrosis. Chen WY; Wu YH; Tsai TH; Li RF; Lai AC; Li LC; Yang JL; Chang YJ Theranostics; 2021; 11(6):2594-2611. PubMed ID: 33456562 [No Abstract] [Full Text] [Related]
5. Type 2 innate lymphoid cells are protective against hepatic ischaemia/reperfusion injury. Cao Q; Wang R; Niu Z; Chen T; Azmi F; Read SA; Chen J; Lee VWS; Zhou C; Julovi S; Huang Q; Wang YM; Starkey MR; Zheng G; Alexander SI; George J; Wang Y; Harris DCH JHEP Rep; 2023 Oct; 5(10):100837. PubMed ID: 37691688 [TBL] [Abstract][Full Text] [Related]
6. A novel type-2 innate lymphoid cell-based immunotherapy for cancer. Saranchova I; Xia CW; Besoiu S; Finkel PL; Ellis SLS; Kari S; Munro L; Pfeifer CG; Fazli L; Gleave ME; Jefferies WA Front Immunol; 2024; 15():1317522. PubMed ID: 38524132 [TBL] [Abstract][Full Text] [Related]
7. Type 2 innate lymphoid cells regulation by regulatory T cells attenuates atherosclerosis. Gao X; Lin J; Zheng Y; Liu S; Liu C; Liu T; Wang B; He S; Li D J Mol Cell Cardiol; 2020 Aug; 145():99-111. PubMed ID: 32526223 [TBL] [Abstract][Full Text] [Related]
8. The ST2 Wachtendorf S; Jonin F; Ochel A; Heinrich F; Westendorf AM; Tiegs G; Neumann K Front Immunol; 2024; 15():1351405. PubMed ID: 38571949 [TBL] [Abstract][Full Text] [Related]
9. Potentiating Tissue-Resident Type 2 Innate Lymphoid Cells by IL-33 to Prevent Renal Ischemia-Reperfusion Injury. Cao Q; Wang Y; Niu Z; Wang C; Wang R; Zhang Z; Chen T; Wang XM; Li Q; Lee VWS; Huang Q; Tan J; Guo M; Wang YM; Zheng G; Yu D; Alexander SI; Wang H; Harris DCH J Am Soc Nephrol; 2018 Mar; 29(3):961-976. PubMed ID: 29295873 [TBL] [Abstract][Full Text] [Related]
10. IL-4 production by group 2 innate lymphoid cells promotes food allergy by blocking regulatory T-cell function. Noval Rivas M; Burton OT; Oettgen HC; Chatila T J Allergy Clin Immunol; 2016 Sep; 138(3):801-811.e9. PubMed ID: 27177780 [TBL] [Abstract][Full Text] [Related]
11. Type 2 innate lymphoid cell suppression by regulatory T cells attenuates airway hyperreactivity and requires inducible T-cell costimulator-inducible T-cell costimulator ligand interaction. Rigas D; Lewis G; Aron JL; Wang B; Banie H; Sankaranarayanan I; Galle-Treger L; Maazi H; Lo R; Freeman GJ; Sharpe AH; Soroosh P; Akbari O J Allergy Clin Immunol; 2017 May; 139(5):1468-1477.e2. PubMed ID: 27717665 [TBL] [Abstract][Full Text] [Related]
12. Systemic administration of IL-33 induces a population of circulating KLRG1 Guillerey C; Stannard K; Chen J; Krumeich S; Miles K; Nakamura K; Smith J; Yu Y; Ng S; Harjunpää H; Teng MW; Engwerda C; Belz GT; Smyth MJ Immunol Cell Biol; 2021 Jan; 99(1):65-83. PubMed ID: 32748462 [TBL] [Abstract][Full Text] [Related]
13. The IL-25/ILC2 axis promotes lung cancer with a concomitant accumulation of immune-suppressive cells in tumors in humans and mice. Bahhar I; Eş Z; Köse O; Turna A; Günlüoğlu MZ; Çakır A; Duralı D; Magnusson FC Front Immunol; 2023; 14():1244437. PubMed ID: 37781372 [TBL] [Abstract][Full Text] [Related]
14. IL-2 is a critical regulator of group 2 innate lymphoid cell function during pulmonary inflammation. Roediger B; Kyle R; Tay SS; Mitchell AJ; Bolton HA; Guy TV; Tan SY; Forbes-Blom E; Tong PL; Köller Y; Shklovskaya E; Iwashima M; McCoy KD; Le Gros G; Fazekas de St Groth B; Weninger W J Allergy Clin Immunol; 2015 Dec; 136(6):1653-1663.e7. PubMed ID: 26025126 [TBL] [Abstract][Full Text] [Related]
15. Low-Dose Interleukin-2 Combined With Rapamycin Led to an Expansion of CD4 Hu M; Hawthorne WJ; Nicholson L; Burns H; Qian YW; Liuwantara D; Jimenez Vera E; Chew YV; Williams L; Yi S; Keung K; Watson D; Rogers N; Alexander SI; O'Connell PJ Diabetes; 2020 Aug; 69(8):1735-1748. PubMed ID: 32381646 [TBL] [Abstract][Full Text] [Related]
16. Unique Phenotypes of Heart Resident Type 2 Innate Lymphoid Cells. Deng Y; Wu S; Yang Y; Meng M; Chen X; Chen S; Li L; Gao Y; Cai Y; Imani S; Chen B; Li S; Deng Y; Li X Front Immunol; 2020; 11():802. PubMed ID: 32431711 [TBL] [Abstract][Full Text] [Related]
18. Th2 cell-derived IL-4/IL-13 promote ILC2 accumulation in the lung by ILC2-intrinsic STAT6 signaling in mice. Symowski C; Voehringer D Eur J Immunol; 2019 Sep; 49(9):1421-1432. PubMed ID: 31144294 [TBL] [Abstract][Full Text] [Related]
19. A Proinflammatory Role of Type 2 Innate Lymphoid Cells in Murine Immune-Mediated Hepatitis. Neumann K; Karimi K; Meiners J; Voetlause R; Steinmann S; Dammermann W; Lüth S; Asghari F; Wegscheid C; Horst AK; Tiegs G J Immunol; 2017 Jan; 198(1):128-137. PubMed ID: 27872212 [TBL] [Abstract][Full Text] [Related]
20. Development and function of regulatory innate lymphoid cells. Thomas CM; Peebles RS Front Immunol; 2022; 13():1014774. PubMed ID: 36275689 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]